Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02719834 · ClinicalTrials.gov registry record
Behavioral Expressions in Alzheimer's Disease
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 4
- Enrollment target
NCT02719834 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 4 participants.
The verdict
NCT02719834 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 4 participants
- Enrollment target
Study Summary
Behavioral expressions, such as agitation and aggression, affect up to 90% of persons with dementia and are a major source of patient and caregiver distress, nursing home placement, anti-psychotic medication use, restraints, and increased health care costs. The purpose of the research study is to investigate whether reducing pain reduces behavioral expressions of Alzheimer's disease (agitation and aggression).
Interventions
- DRUG Acetaminophen
- OTHER Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02719834
The ClinicalTrials.gov registry entry for NCT02719834 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Acetaminophen is the first listed.
NCT02719834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02719834 about?
NCT02719834 is a clinical study titled "Behavioral Expressions in Alzheimer's Disease". Behavioral expressions, such as agitation and aggression, affect up to 90% of persons with dementia and are a major source of patient and caregiver distress, nursing home placement, anti-psychotic medication use, restraints, and increased health care costs. The purpose of the research study is to in...
What is the current status of trial NCT02719834?
This trial is currently completed. The enrollment target is 4 participants. The study started on 2016-04. Estimated completion is 2018-02.
What interventions are being tested in trial NCT02719834?
The interventions under investigation include: Acetaminophen (DRUG), Placebo (OTHER).
Who is sponsoring clinical trial NCT02719834?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.